250 Participants Needed

Internet-Based Lifestyle Intervention for Prostate Cancer Survivors

(iLIVE Trial)

Recruiting at 1 trial location
CG
SM
Overseen BySharon McCoy, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: OHSU Knight Cancer Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests an online program called iLIVE, which combines weight loss and resistance training to assist men with prostate cancer who have undergone androgen deprivation therapy (ADT). ADT often leads to weight gain and frailty, potentially lowering quality of life and increasing fall risk. The study aims to determine if iLIVE can address these issues. Men who have had prostate cancer, received ADT for at least six months, are overweight, and show signs of frailty, but are not currently on a structured diet or exercise program, may be suitable for this trial. Participants will either use the iLIVE program or receive usual care, both supported by fitness trackers. As an unphased trial, this study provides a unique opportunity to contribute to research that may improve quality of life for men with prostate cancer.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this internet-based lifestyle intervention is safe for prostate cancer survivors?

Research shows that specific safety information for the iLIVE program, an online lifestyle intervention, is not available. However, similar digital health and web-based lifestyle programs have been well-received, and participants usually find them safe.

These studies often report high retention rates, indicating that participants tend to stay involved. For instance, one study showed that 85.4% of participants remained engaged at three weeks, increasing to 91% at 12 weeks. This suggests that people find the program easy to follow and safe.

In summary, while direct safety data for the iLIVE program is lacking, similar programs have proven safe for participants in past studies.12345

Why are researchers excited about this trial?

Researchers are excited about the Internet-Based Lifestyle Intervention for prostate cancer survivors because it's a unique approach that combines digital tools and social support for health improvement. Unlike traditional care, which often focuses on in-person sessions and general health advice, this intervention offers personalized, interactive online weight loss programs and group-based resistance training. It leverages technology such as Fitbits and smart scales to provide real-time feedback and motivation, potentially enhancing engagement and adherence to lifestyle changes. This could lead to better long-term health outcomes for prostate cancer survivors by seamlessly integrating modern technology with healthy lifestyle practices.

What evidence suggests that iLIVE is effective for improving obesity and frailty in prostate cancer survivors?

Research shows that the iLIVE program, available to participants in this trial, combines online weight loss advice with group exercise and may help improve obesity and frailty in men with prostate cancer who have undergone hormone therapy. This therapy often leads to weight gain, weakness, and obesity, which can lower quality of life and increase fall risk. Studies suggest that lifestyle programs like iLIVE can promote healthier weight and strength. Early results from similar programs indicate improvements in physical health and potential reductions in frailty. Therefore, iLIVE offers a promising approach to enhancing the health of prostate cancer survivors facing these challenges.12678

Who Is on the Research Team?

Winters-Stone Exercise Lab | OHSU

Kerri Winters-Stone

Principal Investigator

OHSU Knight Cancer Institute

Are You a Good Fit for This Trial?

This trial is for English-speaking men over 18 with prostate cancer who've had at least 6 months of ADT in the past decade, are obese but not morbidly so (BMI >30 to <50), show signs of frailty, and have internet access. They shouldn't be on a diet or exercise plan, have other active cancers except non-melanoma skin cancer, or any condition that affects weight/body composition like Cushing's syndrome.

Inclusion Criteria

I do not plan to start additional cancer treatment within 6 months.
I have undergone hormone therapy for at least 6 months in the past decade.
Verbal informed consent following review of an information sheet
See 9 more

Exclusion Criteria

Contraindication to moderate intensity exercise
I have an active cancer other than non-melanoma skin cancer.
I have lost more than 5% of my weight without trying in the last year.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive online access to an interactive weight loss website and participate in online group-based resistance training sessions (iLIVE). They also use a Fitbit fitness tracker and Aria smart scale.

6 months
Online sessions and self-monitoring

Follow-up

Participants are monitored for changes in obesity, frailty, and other health outcomes after the intervention.

6 months
Remote assessments at 3, 6, and 12 months

What Are the Treatments Tested in This Trial?

Interventions

  • iLIVE
Trial Overview The iLIVE program is being tested to see if it can help reduce obesity and improve frailty in prostate cancer survivors treated with ADT. It includes an online weight loss plus resistance training intervention compared against standard care through random assignment.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (iLIVE)Experimental Treatment2 Interventions
Group II: Arm II (usual care)Active Control1 Intervention

iLIVE is already approved in United States for the following indications:

🇺🇸
Approved in United States as iLIVE for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

OHSU Knight Cancer Institute

Lead Sponsor

Trials
239
Recruited
2,089,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Oregon Health and Science University

Collaborator

Trials
1,024
Recruited
7,420,000+

University of Alabama at Birmingham

Collaborator

Trials
1,677
Recruited
2,458,000+

Published Research Related to This Trial

The Community of Wellness is a Web-based intervention designed to support prostate cancer survivors in improving their physical activity and dietary habits, with a randomized controlled trial currently enrolling 200 participants to assess its feasibility and acceptability.
Preliminary results will help determine the most effective level of online support needed to promote health behavior changes in men with prostate cancer, potentially informing future scalable health interventions.
Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial.Winters-Stone, KM., Kenfield, SA., Van Blarigan, EL., et al.[2020]
A study involving 202 prostate cancer survivors explored the feasibility of a 12-week web-based lifestyle intervention, identifying five key factors that influenced participant engagement: environment, motivation, preparedness, program design, and program support.
The findings suggest that optimizing technology and health literacy, customizing program content, and leveraging support from healthcare providers and family can enhance the effectiveness of web-based interventions for prostate cancer survivors.
Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study.Wang, EY., Graff, RE., Chan, JM., et al.[2020]
A 6-month group-based lifestyle program for prostate cancer patients did not lead to significant improvements in quality of life or physical activity levels, despite good attendance and positive reception from participants.
While the program improved several cognitive-behavioral skills related to physical activity, it was not effective enough to promote routine physical activity among the patients, indicating that additional strategies may be needed.
Active for Life After Cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients.Carmack Taylor, CL., Demoor, C., Smith, MA., et al.[2022]

Citations

Internet-Based Lifestyle Intervention to Eradicate Obese ...Using iLIVE may improve obesity and frailty in men with prostate cancer who receive ADT. Eligibility Criteria ...
Project Details - NIH RePORTERThis design allows formal testing of the effectiveness of a combined online, self-directed weight loss + group-based resistance training program (Internet-Based ...
Internet-Based Lifestyle Intervention (iLIVE) to Eradicate ...Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and ...
Web-Based Lifestyle Interventions for Prostate Cancer SurvivorsObjective: This study aims to develop a data-driven grounded theory of web-based engagement by prostate cancer survivors based on their ...
Internet-Based Lifestyle Intervention (iLIVE) to Eradicate ...Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and ...
Internet-Based Lifestyle Intervention for Prostate Cancer ...The research does not provide specific safety data for the Internet-Based Lifestyle Intervention, but it suggests that digital health coaching and web-based ...
Multimodal Telerehabilitation of Rural Patients With ...Prostate cancer has a significant impact on patient quality of life (QoL) directly, as well as through the management of localized disease (such as surgery ...
A Web-based Lifestyle Intervention for Cancer SurvivorsRecruitment was conducted with ease, and retention was high (85.4% at 3 weeks, slightly lower than the 91% retention rate found at 12 weeks in a web-delivered ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security